Pharmaceutical Formulation is a comprehensive process that transforms active pharmaceutical ingredients (APIs) into a final medicinal product. It encompasses a series of intricate steps to design and develop formulations that ensure the optimal delivery, stability, and efficacy of medications.
The formulation process begins with a thorough understanding of the chemical and physical properties of the active ingredients. Considerations such as dosage form, route of administration, and patient compliance play crucial roles in pharmaceutical formulation. This process is not only focused on ensuring the effectiveness of the drug but also on providing patients with convenient and acceptable forms of medication. The goal is to develop formulations that maintain stability, control release profiles, and minimize adverse effects.
Integral components of Pharmaceutical Formulation includes:
Quality control and Assurance are, ensuring that each batch meets stringent standards for safety, efficacy, and consistency. Continuous research and development in this field contribute to the evolution of innovative formulations that address specific therapeutic needs and improve the overall patient experience.
At its core, Pharmaceutical formulation is dedicated to the creation of drug products that are not only scientifically robust but also attuned to the needs and experiences of patients.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico